Skip to main content
. 2020 Sep 30;43(12):1205–1210. doi: 10.1007/s40264-020-01002-6
COVID-19 vaccines are being developed at an unprecedented speed leading to concerns about adequate safety assessments before deployment.
There are many entities tasked with assessing and monitoring vaccine safety at the global and national levels and prior experience in enhanced vaccine safety activities.
We have the tools to intensively monitor and assess the safety of COVID-19 vaccines as they are deployed, providing there is coordination and collaboration.